Telomerase activity of the Lugol-stained and -unstained squamous epithelia in the process of oesophageal carcinogenesis by Inai, M et al.
Telomerase is a ribonucleoprotein that synthesizes telomeric
sequence of genes and is important for the stability, replication and
function of chromosomes (Morin, 1989). Numerous studies have
demonstrated that telomerase activity is detected in 80–90% of
human cancerous tissues as well as in most of the cancer cell lines
(Chadeneau et al, 1995; Hiyama et al, 1995; Holt et al, 1996). In
contrast, the activity has been shown to be absent in most normal
human somatic tissues except the proliferative cells of the skin
(Taylor et al, 1996) and those of the small intestine (Hiyama et al,
1996), and also normal T cells entering cell cycle (Yashima et al,
1997). Thus, telomerase is thought to be not only a new marker for
malignancy but also a new target of anticancer therapy. 
Oesophageal squamous cell carcinoma (ESC) is one of the most
common cancers worldwide (Parkin et al, 1999). Its prognosis
remains poor despite recent advances in both diagnosis and
therapy. Indeed, the 5-year survival rate after surgery of patients
with advanced ESC was 15.6%, and that of the patients with early
ESC was 56.7% (Sugimachi et al, 1989). Moreover, multiple
primary ESC is not uncommon (Kuwano et al, 1988; Pesko et al,
1994). These reports support the concept that the entire oesoph-
agus may be considered as one entity of field carcinogenesis. The
elucidation of the carcinogenesis of ESC may have a considerable
effect on early diagnosis and therapy. In advanced ESC, similar to
the other cancers, telomerase activity was detected in approxi-
mately 80% of the cases (Takubo et al, 1997), but telomerase
activity was also present in a considerable number of normal
oesophageal epithelia (Bachor et al, 1999; Ikeguchi et al, 1999). In
order to elucidate the meaning of telomerase activity in normal
oesophageal epithelium, we evaluated telomerase activity in both
cancerous and non-cancerous epithelia of the oesophagus. For this
purpose, we classified oesophageal epithelium according to the
result of Lugol’s iodine staining. Lugol’s iodine staining is an
available method to detect abnormal squamous mucosa easily,
because mature squamous epithelium contains glycogen, which
stains brown with iodine. When normal maturation is disturbed by
inflammation, dysplasia or neoplasm, glycogen is decreased or
absent, and the lesion remains unstained in contrast to the
surrounding mucosa (Mori et al, 1993; Dawsey et al, 1998). 
In addition, since human telomerase reverse transcriptase
(hTERT), a component of human telomerase, plays a key role in
activation of telomerase in cancer cells (Takakura et al, 1998;
Kiaris and Schally, 1999), we did in situ hybridization for hTERT
to clarify localization of telomerase activity in various
oesophageal lesions and in Lugol-stained normal epithelia. 
MATERIALS AND METHODS 
Endoscopic sampling 
All samples were obtained at Kyoto University hospital from July
1996 to April 1998. This study included 11 patients with advanced
ESC and 35 patients who underwent routine endoscopic examina-
tion (46 in total). We obtained written informed consent for
Lugol’s staining and endoscopic sampling before endoscopic
examination. 
Each sample was obtained either by biopsy or by endoscopic
mucosal resection. During endoscopic examination, the oesoph-
agus was stained with 3% Lugol’s solution and 2 samples were
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obtained in the same Lugol-unstained lesion. 2 Lugol-stained
epithelial samples were also obtained from each patient at least
3 cm distant from lesions. These 2 samples were taken close to
each other. If no focal lesion was found, a standard site in the mid-
oesophagus was sampled. One sample from each site was
subjected to pathological examination and fixed in 10% buffered
formalin embedded in paraffin, cut in 5 µ m sections, and stained
with H&E. The other was immediately frozen and stored in liquied
nitrogen for measurement of telomerase activity. If the Lugol-
unstained lesion was too small to take 2 samples, only 1 sample
was obtained for pathological examination. 
Histological analysis 
The sample slides were evaluated by 2 pathologists at our institu-
tion without knowledge of patient’s history or endoscopic view.
The histologic categories were based on criteria of the Japanese
Society for Esophageal Disease (Japanese Society for Esophageal
Disease, 1992). Dysplasia and ESC were classified as follows:
dysplasia; nuclear atypia, such as enlargement, pleomorphism and
hyperchromasia was present in the lower third (mild), in the lower
two thirds or less (moderate), or in the two thirds or more (severe)
of the epithelium; intramucosal ESC: malignant squamous cells
were localized within the mucosal layer; advanced ESC: malig-
nant squamous cells invaded through the muscular layer of
mucosa. In this study, intraepithelial ESC was included in the
severe dysplasia group because Japanese pathologists often make
a diagnosis of intraepithelia ESC for lesions that Western patholo-
gists consider to be severe dysplasia (Ronald et al, 2000). 
Telomerase activity 
The sample was homogenized using pipette with ice-cold lysis
buffer as described (Kim et al, 1994). After being kept on ice for
30 min, the sample was centrifuged for 30 min at 4˚C at 10000 g.
The supernatant was collected and snap frozen in liquid nitrogen
before being stored at –80˚C. The protein concentration was deter-
mined by BCA protein assay kit (Pierce, Rockford, IL). 
At first, we did telomeric repeat amplification protocol (TRAP)
assay (Kim et al, 1994) adding an internal telomerase assay stan-
dard (Wright et al, 1995) to exclude the presence of polymerase
chain reaction (PCR) inhibitors in protein extract (0.5 µ g).
Positive control (KYSE 273, the human ESC cell line (Shimada
et al, 1992), which expressed telomerase activity) and negative
control (no protein) were included in each assay. We analysed
these PCR products by electrophoresis on 15% polyacrylamide gel
and visualized them with SYBR green I nucleic acid gel stain
(FMC, BioProducts, Rockland, ME). 
Then, telomerase activity for semi-quantified analysis was
determined by an additional modified TRAP assay combined with
enzyme-linked immunosorbent assay (EIA) (Cheng et al, 1999).
Primer sequences were described by Krupp et al (1997); (Klapper
et al, 1998). Briefly, 0.5 µ g of protein extract was incubated at
24˚C for 15 min in 50 µ l TRAP reaction buffer (20 mM Tris (pH
8.3), 1 mM EGTA, 63 mM KCl, 0.005% Tween 20, 0.1 mg ml–1
bovine serum albumin, 50 µ M dNTP, 1.5 mM MgCl2), 1 µ g of
biotinylated-TS primer [5′ -AATCCGTCGAGCAGAGTT], 1 µ g
of digoxigeninated CX′ primer [5′ -GTG(CCCTTA)3CCCTAA],
and 2 units of Taq DNA polymerase (GIBCO BRL, Grand Island,
NY) followed by 31 cycles of PCR (94˚C for 30 s, 55˚C for 30 s,
and 72˚C for 90 s). Positive control and negative control were also
included in each assay. PCR products were transferred into
streptavidin-coated microtitre plates (Boehringer Mannheim,
Mannheim, Germany) and incubated at 30˚C for 1 h with horse-
radish peroxidase-conjugated anti-digoxigenin (DIG) antibody
(1:50) (Boehringer Mannheim). After washing with PBS, wells
were incubated with tetramethylbenzidine substrate solution
(Sigma Chemical Co, St Louis, MO) for 10 min at room tempera-
ture and was added to HCl. The absorbance was measured at a
wavelength of 450 nm. All samples, positive control, and negative
control were measured in triplicate and the mean optical density
value was applied for analysis. 
Synthesis of DIG-labelled RNA probes 
We extracted total RNA from KYSE 273 by acid guanidinium
thiocyanate-phenol-chloroform extraction method (Chomczynski
and Sacchi, 1987). In order to synthesize RNA probes, after
reverse transcription using the First Strand cDNA Synthesis kit
(Pharmacia Biotech, Uppsala, Sweden), cDNA corresponding to 1
µ g of RNA was used as a PCR template. After heating at 94˚C for
5 min, 30 cycles of PCR were carried out (94˚C for 30 s, 60˚C for
30 s and 72˚C for 30 s). We designed hTERT primers as follows:
5′ -TTGGGGATGAAGCGGAGTC and 5′ -GGCTCCAGGCA-
CAACGAAC (Nakamura et al, 1997). The 443 bp PCR products
were cloned into pCR II plasmid vector using the TA cloning
system (Invitrogen, Carlsbad, CA). To obtain RNA polymerase
promoters on both sides of the fragment, the inserted fragment
was excised by EcoRI and cloned into pBluescript II KS(+)
(Stratagene, La Jolla, CA). We confirmed the sequence by ALF
autosequencer (Pharmacia Biotech). The sequence between M13
forward and reverse primer site of this plasmid was amplified by
these M13 primers (30 cycles of PCR; 94˚C for 30 s, 55˚C for 30 s
and 72˚C for 30 s). In vitro transcription and labelling with DIG
were made by DIG RNA labelling kit (Boehringer Mannheim).
Transcribed products were recognized by gel electrophoresis and
the contents of DIG-labelled probes were quantified by DIG
nucleic acid detection kit (Boehringer Mannheim). 
In situ hybridization 
Deparaffinized 4-µ m-thick sections were incubated with 5 µ g ml–1
proteinase K (Boehringer Mannheim) at 37˚C for 10 min. After
postfixation in 4% paraformaldehyde for 10 min, sections were
immersed in 0.2 N HCl for 10 min. The sections were immersed in
0.1 mol l–01 triethanolamine (TEA)-HCl (pH 8.0) for 1 min and
acetylated with 0.25% acetic acid in 0.1 M TEA for 10 min. After
washing with PBS, slides were dehydrated in graded ethanol series
and dried. Hybridization was performed in a moist chamber with a
cover glass at 50˚C for 16 h. The hybridization buffer contained
50% formamide, 10% dextran sulfate, 1 × Denhalt’s solution,
0.25% sodium dodesyl sulfate, 200 µ g ml–1 E. coli transfer RNA,
10 mM Tris-HCl (pH 7.6), 0.6M NaCl, 1 mM EDTA and 3 µ g ml–1
of DIG-labelled RNA probe. The slides were then immersed in
50˚C with 5 × standard saline citrate (SSC), incubated in 2 × SSC
containing 50% formamide at 50˚C for 30 min and immersed in
TNE buffer (10 mM Tris-HCl [pH 7.6], 500 mM NaCl, 1 mM
EDTA) at 37˚C for 10 min. After removal of single-stranded RNA
with RNase A (GIBCO BRL) in TNE buffer, slides were washed
with 2 × SSC, 0.2 × SSC twice and 0.1 × SSC at 50˚C for 20 min
each. Signal was detected using DIG nucleic acid detection
kit; sections were washed with buffer 1 and incubated in 1.5%
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were incubated with 250 times diluted alkaline phosphatase-
conjugated goat polyclonal anti-DIG Fab fragment antibody for 30
min, followed by washing in buffer 1. The second antibody was
detected by revealing reagents containing nitroblue tetrazolium
and 5-bromo-4-chloro-3-indoyl phosphate at room temperature for
16 h. The sections were then immersed in TE buffer, washed in
distilled water and mounted with Crystal Mount (Biomeda Corp,
Foster City, CA). 
Statistical analysis 
Statistical analysis was performed by the Mann–Whitney U test
and Scheffe’s multiple comparison. Differences were judged
statistically significant if the P value was <0.05. 
RESULTS 
Telomerase activity in tissue samples 
Tissue samples were obtained from 46 patients. 9 patients had
history of reflux oesophagitis, but none of them were involved
with the active phase of inflammation at the point of endoscopic
examination. We collected 46 cases of Lugol-stained epithelia, 
31 cases of Lugol-unstained lesions (14 oesophagitis, 7 mild
dysplasia, 5 severe dysplasia and 5 intramucosal ESC) and 9
advanced ESC tissues (Table 1). Each of the samples did not
contain PCR inhibitors on the results of modified TRAP assay, we
carried out TRAP-EIA for all samples. 
At first, we evaluated telomerase activity limited to the Lugol-
stained epithelia. We divided them into 5 groups based on their
accompanying lesions: Group A (= control group): not accompa-
nied with any oesophageal lesions; Group B: accompanied by
oesophagitis; Group C: accompanied by mild dysplasia; Group D:
accompanied by severe dysplasia or intramucosal ESC; Group 
E: accompanied by advanced ESC. In this part, we treated severe
dysplasia and intramucosal ESC in the same group, that is, as early
ESC group. One Lugol-stained epithelium (Group E) was
excluded due to lack of enough protein concentration. Mean
telomerase activity of the Lugol-stained epithelia increased with
the abnormal progression of accompanying oesophageal lesions
(Figure 1A). Although Group E did not exhibit significantly higher
mean telomerase activity compared with Group D, mean telom-
erase activity of Group E was the highest of the 5 Lugol-stained
epithelial groups. Lugol-stained epithelia of Group C and Group D
exhibited significantly higher mean telomerase activity than
Group A. Telomerase activities in Group B and Group C varied
among samples. The mean telomerase activity of Group C was
higher than that of Group B, but there was no significant differ-
ence between them. The mean telomerase activity of Group B was
significantly lower than that of Group D and Group E, but there
was no significant difference between Group A and Group B. 
Figure 1B shows telomerase activities of various Lugol-
unstained lesions and advanced ESC. Although there was no
significant difference between severe dysplasia and other lesions,
mean telomerase activity of the Lugol-unstained epithelia
increased with the severity of the lesions. There was the tendency
that almost all the telomerase activities of cancerous lesions
showed higher optical density value above 1.200. 
As compared Lugol-stained epithelium with accompanied
Lugol-unstained lesion in each group, mean telomerase activity
was significantly higher in Lugol-unstained lesion with exception
of Group C (Figure 2). In addition, almost all the telomerase activ-
ities were up-regulated in each Lugol-unstained lesion compared
with the Lugol-stained epithelium obtained from the same patient.
9 Lugol-stained epithelia with history of reflux oesophagitis
exhibited relatively high telomerase activity compared with other
Lugol-stained epithelia. 6 of these 9 cases could be obtained both
Lugol-stained epithelium and Lugol-unstained lesion. As for these
6 cases, 2 oesophagitis and 2 early ESC exhibited up-regulation
of telomerase activity compared with Lugol-stained epithelium,
but in 2 cases of mild dysplasia telomerase activity was not up-
regulated. 
Expression of hTERT mRNA in the oesophageal
tissues 
hTERT signal was revealed in nucleus and cytoplasm. We defined
intensity of cytoplasm of the surface epithelium as control and
compared relative signal intensity of various cells. In situ
hybridization for hTERT in Lugol-stained epithelium revealed no
apparent signal (Figure 3A) with a few exceptions. Lugol-stained
epithelium expressed hTERT signal was obtained from a patient
with intramucosal ESC (Figure 3B). In this sample, hTERT signal
was observed in basal and para-basal layers and there were no
cancer cells. In the oesophagitis, lymphocytes and regenerative
epithelial cells expressed weak signal (Figure 3C). hTERT signal
of mild dysplasia was observed in proliferative cells that showed mild
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Table 1 Summary of sample 
Sampling number of accompanied lesion 
Group of stained  Number of stained  Oesophagitis Mild dysplasia Severe  Intramucosal  Advanced  
epitheliuma epithelium dysplasia squamous squamous 
cell carcinoma cell carcinoma
A6 –– – –
B1 4 7 –– – –
C6 0 5 –– –
D9 2 2 3 5 –
E1 1 5 0 2 0 9
Total 46 14 7 5 5 9
aGroup A: not accompanied with any Lugol-unstained lesions or advanced squamous cell carcinoma; Group B: accompanied by oesophagitis; Group C:
accompanied by mild dysplasia; Group D: accompanied by severe dysplasia or intramucosal squamous cell carcinoma; Group E: accompanied by
advanced squamous cell carcinoma.
BJOC 01-2032 1006-1013  1/10/01  11:43 am  Page 1008Telomerase activity in oesophageal carcinogenesis 1009
British Journal of Cancer (2001) 85(7), 1006–1013 © 2001 Cancer Research Campaign
atypia of nuclei (Figure 3D). Regenerative cells and lymphocytes and
dysplastic cells showed a similar and relatively weak intensity.
The signal intensity of basal and para-basal layer cells in Figure
3B was relatively higher than the above 2 samples. 
On the other hand, almost all the advanced cancer cells clearly
showed higher intensity than those described above (Figure 3F).
The signal intensity of hTERT in the cytoplasm of cancer cells
varied. Severe dysplasia and intramucosal ESC showed similar
signal intensity with each other, and intramucosal ESC contained
strong signal that was comparable to the signal of advanced ESC
(Figure 3E). 
There appeared to be a trend towards an increase in the intensity
of hTERT signal with an increase in the severity of the cellular
atypia in Lugol-unstained lesions and advanced ESC, but we could
find no correlation between signal intensity of hTERT and telom-
erase activity in Lugol-stained epithelia and in oesophagitis (data
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Figure 1 Box-and-whisker plot of telomerase activity in samples. Telomerase activities were determined by TRAP-EIA. The bottom and top edges of the box
mark the 25th and the 75th percentiles. The centre horizontal line is drawn at the sample median. The centre vertical lines drawn from the boxes extend to the
10th or 90th percentiles. Circles identify outside values. *P < 0.05; **P < 0.01. (A) Telomerase activity of the Lugol-stained epithelia classified by accompanying
lesions. Group A: not accompanied with any lesions, Group B: accompanied by oesophagitis, Group C: accompanied by mild dysplasia, Group D: accompanied
by early ESC (severe dysplasia or intramucosal ESC), Group E: accompanied by advanced ESC. (B) Telomerase activities of the Lugol-stained normal epithelia
(Group A), Lugol-unstained epithelia (esophagitis, mild dysplasia, severe dysplasia, and intramucosal ESC), and advanced ESC 
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Figure 2 Comparison of telomerase activity determined by TRAP-EIA between Lugol-stained epithelia and accompanied lesions. Samples obtained from
same patient are connected. × is revealed telomerase activity of samples with history of reflux esophagitis. Group B: accompanied by esophagitis, Group C:
accompanied by mild dysplasia, Group D: accompanied by early ESC (severe dysplasia or intramucosal ESC), Group E: accompanied by advanced ESC. 
*P < 0.05; **P < 0.01 
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Figure 3 Distribution of hTERT mRNA signal in oesophageal tissues detected by in situ hybridization. No signal was present in Lugol-stained normal epithelia
(A). hTERT signal was seen in basal and para-basal layers of Lugol-stained normal epithelia accompanied by intramucosal ESC (B). In oesophagitis,
lymphocytes and regenerative cells exhibited weak signal (C). Intensity of dysplastic cells in mild dysplasia was similar to that of the regenerative cells of the
esophagitis (D). Several cancer cells expressed strong signal in intramucosal ESC (E). Almost all the advanced cancer cells expressed strong intensity 
(F). Anti-sense; stained with anti-sense hTERT probe. Sense; stained with sense hTERT probe. Scale bars represent 50 µ m 
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DISCUSSION 
In this study, we semi-quantified telomerase activity in both
cancerous and non-cancerous epithelia of the oesophagus using
TRAP-EIA to elucidate the meaning of telomerase activity in
various states of the oesophagus. 
Interestingly, we found that the levels of telomerase activity in
the Lugol-stained epithelia accompanied with ESC were very high
and that telomerase activity of Lugol-stained epithelia increased
with the progression of accompanying oesophageal lesions. 
Because there are many reports that telomerase activity is
absent in most normal human somatic tissues, it is unexpected that
the Lugol-stained normal epithelia accompanying ESC exhibited
such a high level of telomerase activity. Koyanagi et al reported
that 10% of normal oesophageal tissue accompanied by advanced
ESC showed telomerase activity which was derived from the
microinvasion of cancer cells (Koyanagi et al, 1999). In our study,
we detected no cancer cells in the Lugol-stained epithelia with H
& E staining. Of course, it is difficult to completely rule out the
presence of cancer cells in entire samples, but this is unlikely since
almost all the telomerase activities in the Lugol-stained epithelia
accompanying ESC were high in this study. This discrepancy may
be ascribed to the difference of sampling method. They treated
surgical specimens; on the other hand, we treated biopsy and EMR
specimens Biopsy specimens can be frozen immediately compared
with surgical specimens. Telomerase activity may decrease during
the resection. Bachor et al also showed that biopsy samples in
normal gastrointestinal mucosa exhibited high telomerase activity
(Bachor et al, 1999). They explain that the difference between
these 2 types of sampling may be caused by the difference of the
proportion of connective tissue. It is known that connective tissue
is telomerase-negative (Harle-Bachor and Boukamp, 1996) and
may thereby dilute the activity of epithelial cells. In addition, it
contains proteins that may inhibit Taq polymerase activity and
prevent amplification of telomerase products (Nakamura et al,
1999). 
We also found that some Lugol-stained epithelia in Group B or
Group C showed high telomerase activities that was comparable
to those in Group D or Group E. These epithelia in Group B and
Group C were obtained from patients with a history of reflux
oesophagitis with a few exceptions. The up-regulation of telom-
erase in Lugol-stained epithelia may be due to an acceleration of
cell cycle to reproduce normal epithelial cell because telomerase is
regarded as a biomarker of cell proliferation (Belair et al, 1997;
Hytiroglou et al, 1998). Their endoscopic findings did not show
the presence of active inflammation in the oesophagus but repro-
ductive action may be continued after active phase of reflux
oesophagitis. We did in situ hybridization for hTERT to clarify the
derivation of telomerase activity. Although we could not detect
hTERT signals in some Lugol-stained epithelia despite their high
telomerase activity, Lugol-stained epithelia accompanied ESC
expressed hTERT signals in basal and para-basal layers. Thus we
assume that basal and para-basal cells will produce telomerase. 
From these results, telomerase activity in Lugol-stained epithe-
lium may show the cellular stability that is influenced by the
process of carcinogenesis or reproduction. The oesophagus is
easily affected by external stimulation, such as food intake,
tobacco smoking, drinking, and so on, and then epithelial regener-
ation is repetitious in the entire oesophagus. This phenomenon is
characteristic in the oesophagus and this may up-regulate telom-
erase activity in the normal oesophagus. Frequent regeneration
and high telomerase activity may lead to canceration in the
oesophagus. Indeed, the frequency of multiple ESC was higher in
patients with abundant Lugol-unstained lesions than in patients
with unicentric cancer and individuals who had no exposure to
tobacco smoking and drinking would be less likely to exhibit small
areas unstained (Nakanishi et al, 1998). A few studies also
analysed telomerase activity in normal samples and showed the
usefulness of telomerase activity to predict the clinical course of
the diseases (Cheng et al, 1998). 
According to the Lugol-unstained lesions and advanced ESC,
telomerase activity increased relative to the severity of the disease.
Similar results were reported concerning Lugol-unstained lesions,
but there was no evaluation of oesophagitis and advanced ESC
(Koyanagi et al, 2000). The wide range of telomerase activity in
oesophagitis may show the degree of inflammation and the repro-
ductive activity in each sample. Indeed, we demonstrated that
lymphocytes and regenerative cells exhibited hTERT signal in the
oesophagitis samples, though the signal was relatively weak. In
this study, almost all the mild dysplasia exhibited higher telom-
erase activity than the Lugol-stained normal control Group A and
mean telomerase activity of mild dysplasia was similar to that of
oesophagitis. Moreover, the signal intensity of dysplastic cells was
also relatively weak. This finding suggests that mild dysplasia
would be an immature epithelium in the middle of the normal
reproduction after inflammation or a neoplastic epithelium which
grows very slowly. Severe dysplasia exhibited higher telomerase
activity than mild dysplasia with no significant difference. This
result would be due to the shortage of cases of severe dysplasia.
Moreover, intramucosal ESC exhibited significantly higher mean
telomerase activity than mild dysplasia. Additional up-regulation
of telomerase was shown in advanced ESC. There was a similar
tendency in the analysis of in situ hybridization. These data
suggest that telomerase activity is up-regulated in the early stage
of the oesophageal carcinogenesis and may be a critical role in the
progression of ESC. 
Figure 2 shows that telomerase activity of ESC increased
compared with Lugol-stained epithelia. It seems that carcinogen-
esis would require not only telomerase activation but also some
additional factors that could make further up-regulation of telom-
erase. The regulatory mechanism of telomerase activity is
unknown at present. Several groups have demonstrated that c-myc
mRNA or Myc participates in telomerase activation (Fujimoto and
Takahashi, 1997; Wang et al, 1998), and that the TERT promoter
contains c-Myc-binding sites that mediate TERT transcriptional
activation (Wu et al, 1999). The amplification of c-myc is not
frequent in the ESC (Lu et al, 1988; Esteve et al, 1993). On the
other hand, overexpression of c-myc mRNA was detected in the
normal mucosa adjacent to tumour in 23% of patients with ESC
(Schrier and Peltenburg, 1993). One group has reported that the
ectopic expression of the hTERT in combination with 2 oncogenes
results in direct tumorigenic conversion of normal human epithe-
lial cells (Hahn et al, 1999). Thus, the analysis of the regulatory
mechanism of telomerase activity is important for the elucidation
of carcinogenesis in the oesophagus. 
In our study, there appeared to be a trend toward an increase of
hTERT expression with an increase in the severity of the cellular
atypia in Lugol-unstained lesions and advanced ESC, but there is
no correlation between hTERT expression and telomerase activity
in Lugol-stained epithelia and in oesophagitis. This disparity may
be partially due to our own technical problem. But it also may be
due to low abundance of this gene or short expression of hTERT
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mRNA in normal oesophageal samples compared with cancerous
tissues. Indeed there are various reports about the relationship
between telomerase activity level and the hTERT mRNA expres-
sion. In hepatic tissues, there was a clear correlation between
telomerase activity level and the hTERT expression level
(Nakayama et al, 1998). On the other hand, various levels of
hTERT expression were observed in normal and cancer tissues
without telomerase activity (Nakamura et al, 1999; Rohde et al,
2000). In an immunohistochemical study of the hTERT protein in
colorectal tumour, telomerase activity and hTERT expression at
both the mRNA and protein levels were found to be generally
higher in the tumour part than in the non-tumour part, but expres-
sion of hTERT at mRNA or protein level did not always result in
significant expression of telomerase activity (Tahara et al, 1999).
Nakano et al were also unable to find a correlation between telom-
erase activity and hTERT expression and suggested that additional
regulation, such as modulation of the hTERT gene product or coor-
dination with other unknown proteins, may participate in the acti-
vation of telomerase (Nakano et al, 1998). To resolve these
differences, we need some method which directly enables us to
evaluate telomerase activity at the cellular level. 
In conclusion, telomerase activity in Lugol-stained area may
predict the development of oesophageal abnormal mucosa, espe-
cially, cancer. There is a possibility that high telomerase activity in
normal oesophageal epithelium leads to a tendency to canceration
and then the entire oesophagus may be considered as one entity of
field carcinogenesis. Therefore, high telomerase activity in the
Lugol-stained areas can not be used as a diagnostic marker for
ESC but may be a marker of a high-risk group for ESC. Additional
study is required to clarify the regulatory mechanism of telomerase
activity in oesophageal carcinogenesis. 
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